Latest news with #psychedelicdrugs


Bloomberg
02-06-2025
- Business
- Bloomberg
Thiel-Backed Psychedelic Drugmaker Atai to Combine With Beckley
Atai Life Sciences NV agreed to buy full control of smaller UK rival Beckley Psytech Ltd. and raised $30 million in fresh equity, as it seeks to cement its position as one of the leading makers of psychedelic drugs for mental health conditions. The German company, which acquired about a 36% stake in Beckley last year, will purchase the remaining shares in an all-stock deal, it said in a statement Monday. The deal values Oxford-based Beckley at about $390 million, according to the statement.
Yahoo
17-05-2025
- Health
- Yahoo
FDA commissioner says research on psychedelic treatment ‘top priority'
FDA Commissioner Dr. Marty Makary tells Jillian Michaels on NewsNation's 'On Balance' that the agency needs to 'listen to doctors' and expand its research on psychedelic drugs, calling it a top priority for the Trump administration. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.